SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
____________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): ~~July~~September 2612, 2017 ~~HypGen Inc~~

HYPGEN, INC.

(Exact name of registrant as specified in its charter)

Nevada	333-207383	37-1780402
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1999 Avenue of the Stars Suite 1100 Century City, CA	90067
(Address of principal executive offices)	(Zip Code)
Registrant’s telephone number, including area code: (000) 000-000

1999 Avenue of the Stars Suite 1100 Century City, CA 90067
(Address of principal executive offices)

424-253-1201
(Registrant’s telephone number)

Mega Bridge, Inc. #501 Madison Avenue 14th Floor New York, New York 10022 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~SECTION~~Item 54.01 –Changes ~~Corporate~~In ~~Governance~~Registrant’s ~~and Management~~Certifying Public Accountant

~~ITEM~~(a) ~~5.03~~Dismissal ~~Amendments to Articles~~ of ~~Incorporation~~Bharat orParikh ~~Bylaws;~~& ~~Change~~Associates ~~in Fiscal Year~~(“BPA”).

On September ~~July 18~~12, 2017, we(the ~~filed~~“Dismissal ~~Articles~~Date”), ~~of Merger with~~ the ~~Secretary~~Board of ~~State~~Directors of ~~Nevada in order to effectuate a merger with our wholly-owned subsidiary~~HypGen, ~~HypGen~~ Inc. ~~Shareholder approval was not required under Section 92A.180 of~~ (the ~~Nevada~~“Company”) ~~Revised Statutes. As part of the merger, our board of directors authorized~~determined ~~a change in our name~~ to ~~“HypGen~~dismiss ~~Inc”~~BPA ~~and~~as ~~our~~its ~~Articles~~independent ofregistered ~~Incorporation~~public ~~have~~accounting ~~been amended to reflect this name change~~firm.

AThe report ~~copy~~of BPA on the audited financial statements of the ~~Articles~~Company for the fiscal years ended May 31, 2017 and May 31, 2016 did not contain any adverse opinion or disclaimer of ~~Merger~~opinion, isnor ~~attached~~was it qualified or modified as to ~~this~~uncertainty, ~~Current~~audit ~~Report~~scope or accounting asprinciples, ~~Exhibit~~except ~~3.1~~a ~~and~~going isconcern ~~incorporated~~qualification byon ~~reference~~the ~~herein~~Company’s financial statements for the fiscal years ended May 31, 2017 and May 31, 2016.

InDuring the ~~connection~~Company’s ~~with~~two most recent fiscal years, the ~~name~~subsequent ~~change~~interim periods thereto, weand ~~have~~through the ~~following~~Dismissal ~~new~~Date, ~~CUSIP~~there ~~number:~~were ~~44916J~~no ~~109.~~disagreements We(as ~~have~~defined ~~submitted~~in ~~the~~Item ~~required~~304 ~~information~~of Regulation S-K) with BPA on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to ~~FINRA~~the ~~and~~satisfaction weof BPA, would have ~~been~~caused ~~provided~~it ato ~~market~~make ~~effective~~reference ~~date~~in connection with its opinion to the subject matter of ~~August~~the disagreement. Further, 1during the Company’s two most recent fiscal years, ~~2017.~~the ~~Our~~subsequent ~~common~~interim ~~stock~~periods ~~will~~thereto, ~~trade~~and ~~under~~through the ~~symbol~~Dismissal ~~“HPGN”~~Date, there ~~that~~were ~~more~~no ~~resembles~~reportable ~~our~~events ~~new~~(as ~~name~~defined in Item 304(a)(1)(v) of Regulation S-K).

OnThe Company ~~July~~provided ~~26,~~BPA ~~2017,~~with ~~we filed~~ a ~~Certificate~~copy of ~~Amendment~~ tothis ~~the~~Report ~~Company’s~~prior ~~Articles~~to ofits ~~Incorporation~~filing (with the ~~“Certificate~~Securities ofand ~~Amendment”)~~Exchange ~~with~~Commission (the ~~Secretary of State~~“SEC”) ofand ~~Nevada.~~requested ~~The~~BPA ~~Certificate~~to offurnish ~~Amendment amends Article III of~~ the Company’s ~~Articles~~with ofa ~~Incorporation~~letter addressed to ~~authorize~~ the ~~issuance of up to two (2~~SEC,~~000,000)~~ ~~shares~~stating ofwhether ~~Preferred~~or ~~Stock,~~not ~~par~~it ~~value~~agrees ~~$0.001~~with ~~per share, which have~~ the ~~right~~statements made toabove ~~cast~~and, ~~one~~if ~~thousand (1~~not,~~000) votes~~ ~~for~~stating ~~each share held of record on all matters submitted to a vote of holders of~~ the ~~Corporation’s~~respects ~~common~~in ~~stock,~~which ~~including the~~they ~~election~~do ofnot ~~directors, and all other matters required by law~~agree. A ~~Our~~copy ~~Board~~ of ~~Directors~~such ~~and~~letter awill ~~majority~~be offiled ~~our~~by ~~shareholders approved~~amendment ~~the~~once ~~Certificate~~it ofis ~~Amendment~~received.

As(b) ~~described~~Engagement ~~in the Current Report on Form 8-K filed with the SEC on July 10, 2017, all 2,000,000 shares~~ of ~~Preferred~~Fruci ~~Stock~~Associates ~~were issued pursuant to an Asset Assignment Agreement dated June 28~~II, ~~2017~~PLLC ~~with Chang Holding’s LLC.~~(“Fruci”)

AOn September ~~copy~~12, 2017 (the “Engagement Date”), the Company’s Board of Directors approved the ~~Certificate~~appointment of ~~Amendment~~Fruci as isthe ~~attached~~Company’s independent registered public accounting firm. During the Company’s two most recent fiscal years, the subsequent interim periods thereto, and through the Engagement Date, neither the Company nor anyone on its behalf consulted Anton & Chia regarding either (1) the application of accounting principles to ~~this~~a ~~Current~~specified transaction regarding the Company, ~~Report~~either ascompleted ~~Exhibit~~or 3.proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or (2) any matter regarding the Company that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and isrelated ~~incorporated~~instructions byto ~~reference~~Item ~~herein~~304 of Regulation S-K) or a reportable event (as defined in Item 304(a)(1)(v) of Regulation S-K).

~~SECTION~~Item 9.01. – Financial Statements and Exhibits.

~~ITEM 9.01 Financial Statements and~~ (d) Exhibits

Exhibit No.	Description
3.1	Articles of Merger, dated July 18, 2017
3.2	Certificate of Amendment, dated July 26, 2017

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

SIGNATURES

Exhibit No.

Description

Letter regarding change in certifying accountant (to be filed by amendment)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HypGen Inc

/s/ Dr. McCoy Mortez

Dr. McCoy Mortez CEO

Date: July 31, 2017

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	HYPGEN, INC.
Dated: September 19, 2017	By:	/s/ Dr. McCoy Moretz
		Dr. McCoy Moretz Chief Executive Officer

Filing Compare · HypGen Inc